CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

CELL CALCIUM is a premier journal published by ELSEVIER SCI LTD, focusing on the critical role of calcium in cellular processes, making it an essential read for researchers and professionals in the fields of Cell Biology, Molecular Biology, and Physiology. Having been in publication since 1980, this journal is well-regarded, holding a Q2 ranking in Cell Biology and Molecular Biology, as well as a prestigious Q1 status in Physiology for 2023. With an impressive Scopus ranking that places it in the top 20% of journals in its categories, CELL CALCIUM aims to disseminate original research articles that advance the understanding of calcium signaling mechanisms and their implications in health and disease. Although not available via open access, its insights are critical for advancing knowledge and fostering collaboration within the scientific community. The journal is located in the United Kingdom, with its editorial excellence helping to promote high-impact research that continues to influence both academia and industry.

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

JOURNAL OF GENERAL PHYSIOLOGY, published by Rockefeller University Press, is a leading peer-reviewed journal that has been at the forefront of physiological research since its inception in 1918. With an ISSN of 0022-1295 and an E-ISSN of 1540-7748, this esteemed journal maintains an impressive Q1 ranking in the field of Physiology, reflecting its high-quality contributions to both the basic and applied aspects of physiology. Regularly cited in the scientific community, it ranks 70th out of 193 in the category of Biochemistry, Genetics, and Molecular Biology, showcasing its significant impact within academic circles. The journal publishes original research, reviews, and commentaries, aiming to advance the understanding of physiological mechanisms and their implications across various biological systems. Although not Open Access, the journal remains a vital resource for researchers, professionals, and students dedicated to exploring the depths of cardiopulmonary function, neurophysiology, and cellular biochemical processes. The JOURNAL OF GENERAL PHYSIOLOGY continues to serve as a critical platform for disseminating innovative findings and fostering collaboration among scientists globally.

Welcome to the Korean Journal of Physiology & Pharmacology, a pivotal academic platform dedicated to advancing the disciplines of physiology and pharmacology. Published by the esteemed Korean Journal of Physiology & Pharmacology, this journal has been disseminating valuable research findings since its inception in 1997 and continues to be a critical resource for researchers, professionals, and students in South Korea and beyond. With an ISSN of 1226-4512 and E-ISSN of 2093-3827, it offers insights into various aspects of drug action and physiological mechanisms. Although this journal currently does not subscribe to Open Access, it plays a vital role in bridging the gap between experimental and clinical studies, receiving commendations for its quality. In the 2023 Scopus rankings, it is notably positioned in the Q3 quartile for Pharmacology and Q4 for Physiology, reflecting its commitment to excellence. As the journal converges towards its comprehensive coverage in 2024, it remains a cornerstone for those looking to engage deeply with critical developments in these fields.

EXPERIMENTAL PHYSIOLOGY, published by WILEY, stands as a vital resource in the fields of Nutrition and Dietetics and Physiology, providing high-quality, peer-reviewed research since its inception in 1990. With an impressive categorization into the Q2 quartile in these domains, the journal emphasizes the integration of experimental and clinical findings, making significant contributions to our understanding of physiological processes and nutritional impacts on health. The journal operates within a competitive landscape, ranked significantly in Scopus, showcasing its relevance to both the medical community and nutritional sciences, as evidenced by its rankings in Nursing, Medicine, and Biochemistry. Though it is not currently open access, the journal remains an indispensable tool for researchers, professionals, and students seeking to deepen their knowledge and stay updated on cutting-edge research. With a publication window extending to 2024, EXPERIMENTAL PHYSIOLOGY continues to influence the academic discourse and promote advancements in its respective fields.

Autophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.

Physiological Genomics is a prestigious scholarly journal published by the American Physiological Society, dedicated to advancing the understanding of the genetic underpinnings in physiology. With an ISSN of 1094-8341 and an E-ISSN of 1531-2267, this journal serves as a vital platform for researchers exploring the intersection of genetics and physiological processes. As of 2023, it enjoys a respectable impact factor, particularly standing strong in the Q2 quartile in both Genetics and Physiology categories, illustrating its importance within a competitive landscape. With an impressive rank of #69 out of 193 in Biochemistry, Genetics, and Molecular Biology - Physiology, and #128 out of 347 in Genetics, it reflects a robust commitment to quality research. Committed to fostering innovation, Physiological Genomics provides comprehensive access to groundbreaking studies from 1999 to 2024 and remains a quintessential resource for researchers, professionals, and students alike aiming to enhance their understanding of physiological genomics.

Acta Physiologica is a premier, peer-reviewed journal published by WILEY, dedicated to the dissemination of high-quality research across the field of physiology. With an impressive impact factor reflective of its Q1 category ranking in Physiology for 2023, this journal is a vital resource for researchers, professionals, and students alike, seeking to explore the complexities of biological systems. The journal is indexed with a commendable Scopus rank of #18 out of 193 in its category, placing it within the top 10% of its field, which underscores its influence and citation frequency within the academic community. Acta Physiologica publishes a variety of articles that address fundamental physiological concepts, innovative methodologies, and cross-disciplinary research. With its open access options, the journal ensures that cutting-edge knowledge is readily accessible, fostering an environment of collaboration and advancement in the study of physiology. Spanning from 2006 to 2024, the journal continues to be at the forefront of physiological research and education, encouraging the global sharing of knowledge through its comprehensive content.

The Journal of Cachexia Sarcopenia and Muscle is a premier open-access publication dedicated to advancing the understanding of muscle wasting, cachexia, and related disorders. Published by Wiley, this esteemed journal boasts an impressive impact within its fields, achieving a Q1 classification in both Orthopedics and Sports Medicine, and Physiology (Medical) for 2023. With a Scopus ranking of #4 out of 321 in Orthopedics and Sports Medicine, and #10 out of 113 in Physiology, it firmly positions itself at the forefront of medical research. The journal’s scope includes comprehensive studies, reviews, and innovative clinical trials that contribute to the scientific community’s understanding of muscle health and performance. Since its inception in 2010 as an open-access platform, the Journal of Cachexia Sarcopenia and Muscle has facilitated a growing dialogue among researchers, healthcare professionals, and students, emphasizing its crucial role in tackling the multifaceted challenges posed by muscle diseases. For those invested in the latest research trends and clinical advancements, this journal stands out as a vital resource and reference point.